Enroll patients. Generate evidence.
Regulatory-ready from day one.
Two ways to bring patients into the platform. One governed infrastructure behind both. Start with commercial intelligence — real-time outcomes for your sales and medical affairs teams. Activate regulatory-grade evidence whenever you're ready, on the same patients, with no rebuild.
Two ways in. One platform.
Choose the enrollment path that fits your commercial model — or run both. Every patient enters the same governed, HIPAA-compliant infrastructure regardless of how they arrive.
QR Code Direct-to-Celéri
Place a QR code on product packaging, patient discharge materials, trifolds, or demo kits. Patients scan and enroll directly — no rep account setup, no portal complexity, no site staff required. Two sub-paths let patients move at their own pace.
- Patient scans QR code on packaging, brochure, or sales collateral
- Chooses App Path (custom-branded app or integration with client's existing app) or Direct Enroll (mobile form, app optional later)
- Every patient enters the same 21 CFR Part 11 and HIPAA-compliant platform — eConsent captured digitally against governed registry infrastructure
- Automated PRO sequences begin immediately — NRS, PGIC, PROMIS-29, ODI at defined milestones
- Data flows to sponsor dashboard in real time — no rep action required
CRM-Integrated Enrollment
For commercial organizations that want enrollment embedded directly in the rep workflow. Reps submit patients to the registry from within your existing CRM — no duplicate entry, no separate portal, no change to the pre-procedure process.
- Rep submits patient record from CRM at pre-procedure stage
- Celéri receives enrollment trigger — patient outreach begins automatically
- Every patient enters the same 21 CFR Part 11 and HIPAA-compliant platform — eConsent delivered via SMS or email, no site visit required
- Rep gets enrollment confirmation and milestone alerts back through CRM
- Patient outcomes surface in rep territory dashboard in real time
Enroll. Engage. Signal. Act.
Four steps from patient enrollment to clinical decision — fully automated, no site staff burden.
Enroll
Patient enters the platform via QR scan or CRM trigger. eConsent captured digitally. Tiered consent built in — commercial feedback, registry participation, or both.
Engage
Automated SMS and email outreach sequences deliver PRO assessments at baseline and every clinical milestone. Behaviorally-informed messaging maximizes response rates.
Signal
Outcomes surface in real time — rep territory dashboards, physician-level performance, indication and payer signal analysis. Benchmarked against PainRWD™ Science Cloud comparator data.
Act
Commercial team uses outcomes in physician conversations. Medical affairs uses the same dataset for publication and payer submissions. When ready, activate the Regulatory-Grade Evidence Cohort™ — same patients, no rebuild.
Regulatory-ready from the first patient enrolled.
The Commercial Insights Registry™ is always Layer 1 — it runs from day one of launch and never stops. The Regulatory-Grade Evidence Cohort™ runs on top of it. Start both together, or add regulatory-grade evidence when your signals tell you it's time.
One dataset. Two teams. No version conflict.
The most expensive data in medtech is data that has to be gathered twice. Celéri gives commercial and medical affairs access to the same governed evidence base — each with the view built for their function.
Real-time outcomes intelligence
- Rep territory dashboard: case volume, NRS trends, milestone alerts, open follow-ups
- Physician-level outcomes — blinded patient results available in a clinical conversation
- Signal analysis by indication, payer type, and geography — no data analyst required
- MCID breach alerts routed to the assigned rep automatically
- Site FMV eligibility tracking for participation in the Commercial Insights Program
Publication-grade evidence pathway
- Same governed cohort — draws from identical data, not a parallel extract
- Signal analysis drives cohort scoping before protocol design begins
- Longitudinal PRO dataset: NRS, PROMIS-29, ODI, PGIC, procedure timelines
- Payer dossier and HEOR modeling support via PainRWD™ Science Cloud comparator data
- Celéri Research Group available for biostatistics review and manuscript support
Four views. One governed environment.
Every tab draws from the same HIPAA-compliant data infrastructure — access-controlled by role.
Cohort KPIs anchored to procedure date
The primary leadership view. Answers the central question: "How are our patients actually doing?" NRS trajectory, PGIC distribution, enrollment trends, and 30-day completion — all in a single dashboard updated in real time.
- NRS TrajectoryMean pain scores by timepoint — baseline through 90 days — benchmarked against PainRWD™ Science Cloud
- PGIC DistributionPatient Global Impression of Change at 90 days — the patient-centric outcomes narrative for health system and payer conversations
- Enrollment TrendMonthly enrollment growth by site — tracks rep engagement and site maturation over time
Outcomes by indication, payer, and geography
Gives clinical and market access teams the ability to interrogate outcomes without a data analyst — and doubles as the scoping instrument for the Regulatory-Grade Evidence Cohort™. The team uses signal analysis to confirm the optimal indication, payer segment, and geographic cohort before protocol design begins.
- Indication SignalCase volume and NRS improvement by indication — identifies primary commercial and regulatory targets
- Payer SignalOutcomes by payer type — critical data for market access discussions with commercial and government payers
- Geographic PerformancePatient volume and NRS improvement by state — identifies high-performance regional clusters
Close the loop between rep activity and clinical outcomes
For the first time, commercial leadership can see — in a single governed view — which reps are driving enrollment, which physicians are delivering the strongest outcomes, and which patients are overdue on milestones. The physician outcomes view is sales-enablement safe: reps filter to a physician's patient cohort and present outcomes directly in a clinical conversation, with patient identities blinded.
- Rep PerformanceCases enrolled vs. 30-day completion rate by rep — top performers maintain 86–89% completion
- Physician OutcomesTop physicians by case volume and average NRS improvement — physician-specific data for expansion conversations
- Milestone TrackingPatients pending or overdue by milestone — enables proactive outreach before assessment windows close
Site FMV eligibility — restricted admin view
Tracks milestone completion across all enrolled patients to determine site eligibility for Fair Market Value payments in exchange for Commercial Insights Program participation. Access-controlled to authorized client and Celéri admin only. Celéri surfaces eligibility status — dollar amounts and disbursement decisions remain in your finance workflow.
- Site Eligibility SummaryWhich sites have patients meeting milestone thresholds this period — auditable basis for payment processing
- Milestone Completion FunnelAttrition rates from consent through 90-day completion — identifies sites needing rep follow-up
- Access ControlledRestricted read-only view — not accessible to field team; finance and compliance workflows remain entirely client-side
Leading MedTech & Pharma sponsors.
Talk to a Celéri strategist.
We'll help you identify the right enrollment path and evidence tier for your product and commercial stage — whether you're at launch or seeking evidence renewal for a mature product line.
